Updates of Generic Drug Consistency Evaluation Work in China

Until February 13^th, 2019, the China Center of Drug Evaluation, National Medical Products Administration (CDE-NMPA) has announced 126 drugs’ information which passed the consistency evaluation on its website. The public information includes the basic information of drugs and companies, the BE test data and product specifications. According to the third-party statistics, the total number of acceptances for consistency evaluation by CDE-NMPA has reached 906, including 290 varieties of 309 companies.